全文获取类型
收费全文 | 2901篇 |
免费 | 179篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 72篇 |
妇产科学 | 100篇 |
基础医学 | 461篇 |
口腔科学 | 131篇 |
临床医学 | 261篇 |
内科学 | 655篇 |
皮肤病学 | 17篇 |
神经病学 | 212篇 |
特种医学 | 65篇 |
外科学 | 483篇 |
综合类 | 40篇 |
预防医学 | 149篇 |
眼科学 | 28篇 |
药学 | 152篇 |
中国医学 | 7篇 |
肿瘤学 | 225篇 |
出版年
2023年 | 20篇 |
2022年 | 35篇 |
2021年 | 83篇 |
2020年 | 45篇 |
2019年 | 81篇 |
2018年 | 83篇 |
2017年 | 56篇 |
2016年 | 82篇 |
2015年 | 70篇 |
2014年 | 110篇 |
2013年 | 143篇 |
2012年 | 247篇 |
2011年 | 247篇 |
2010年 | 161篇 |
2009年 | 134篇 |
2008年 | 199篇 |
2007年 | 191篇 |
2006年 | 191篇 |
2005年 | 185篇 |
2004年 | 170篇 |
2003年 | 122篇 |
2002年 | 126篇 |
2001年 | 18篇 |
2000年 | 11篇 |
1999年 | 27篇 |
1998年 | 17篇 |
1997年 | 25篇 |
1996年 | 17篇 |
1995年 | 16篇 |
1994年 | 16篇 |
1993年 | 12篇 |
1992年 | 18篇 |
1991年 | 14篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 10篇 |
1987年 | 11篇 |
1986年 | 5篇 |
1985年 | 11篇 |
1984年 | 9篇 |
1983年 | 4篇 |
1982年 | 9篇 |
1981年 | 4篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 13篇 |
1977年 | 5篇 |
1973年 | 3篇 |
1964年 | 3篇 |
1894年 | 3篇 |
排序方式: 共有3102条查询结果,搜索用时 15 毫秒
91.
Patients suffering from primary sclerosing cholangitis (PSC) show considerable differences regarding clinical manifestations (i.e. large duct versus small-duct PSC, presence or absence of concomitant inflammatory bowel disease), disease progression, risk for malignancy and response to therapy, raising the question whether PSC may represent a mixed bag of diseases of different aetiologies. The growing list of secondary causes and diseases 'mimicking' or even overlapping with PSC (e.g. IgG4-associated sclerosing cholangitis), which frequently causes problems in clear-cut discrimination from classic PSC and the emerging knowledge about potential disease modifier genes (e.g. variants of CFTR, TGR5 and MDR3) support such a conceptual view. In addition, PSC in children differs significantly from PSC in adults in several aspects resulting in distinct therapeutic concepts. From a clinical perspective, appropriate categorization and careful differential diagnosis are essential for the management of concerned patients. Therefore, the aim of the current review is to summarize current and evolving pathophysiological concepts and to provide up-to-date perspectives including future treatment strategies for PSC. 相似文献
92.
93.
94.
95.
96.
97.
First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes – Chapter 1: update on national regulatory frameworks pertinent to clinical islet xenotransplantation 下载免费PDF全文
Emanuele Cozzi Ralf R. Tönjes Pierre Gianello Léo H. Bühler Gina R. Rayat Shinichi Matsumoto Chung‐Gyu Park Ivo Kwon Wei Wang Philip O'Connell Stewart Jessamine Robert B. Elliott Takaaki Kobayashi Bernhard J. Hering 《Xenotransplantation》2016,23(1):14-24
Islet xenotransplantation represents an attractive solution to overcome the shortage of human islets for use in type 1 diabetes. The wide‐scale application of clinical islet xenotransplantation, however, requires that such a procedure takes place in a specifically and tightly regulated environment. With a view to promoting the safe application of clinical islet xenotransplantation, a few years ago the International Xenotransplantation Association (IXA) published a Consensus Statement that outlined the key ethical and regulatory requirements to be satisfied before the initiation of xenotransplantation studies in diabetic patients. This earlier IXA Statement also documented a disparate regulatory landscape among different geographical areas. This situation clearly fell short of the 2004 World Health Assembly Resolution WHA57.18 that urged Member States “to cooperate in the formulation of recommendations and guidelines to harmonize global practices” to ensure the highest ethical and regulatory standards on a global scale. In this new IXA report, IXA members who are active in xenotransplantation research in their respective geographic areas herewith briefly describe changes in the regulatory frameworks that have taken place in the intervening period in the various geographic areas or countries. The key reassuring take‐home message of the present report is that many countries have embraced the encouragement of the WHO to harmonize the procedures in a more global scale. Indeed, important regulatory changes have taken place or are in progress in several geographic areas that include Europe, Korea, Japan, and China. Such significant regulatory changes encompass the most diverse facets of the clinical application of xenotransplantation and comprise ethical aspects, source animals and product specifications, study supervision, sample archiving, patient follow‐up and even insurance coverage in some legislations. All these measures are expected to provide a better care and protection of recipients of xenotransplants but also a higher safety profile to xenotransplantation procedures with an ultimate net gain in terms of international public health. 相似文献
98.
99.
Brosens IA De Sutter P Hamerlynck T Imeraj L Yao Z Cloke B Brosens JJ Dhont M 《Human reproduction (Oxford, England)》2007,22(6):1725-1729
BACKGROUND: We postulated that impaired endometrial differentiation in women with pelvic endometriosis predisposes for pre-eclampsia. METHODS: A retrospective case-control study set at the University of Ghent IVF centre. The incidence of pre-eclampsia and pregnancy-induced hypertension (PIH) following the clinical and/or laparoscopic diagnosis of endometriosis-associated infertility (case group; n = 245 pregnancies) was compared with the incidence of these obstetric complications in pregnancies following treatment for male-factor infertility (control group; n = 274 pregnancies). Pregnancy data were obtained by searching electronic databases and postal questionnaires. The case and control groups were matched for age, parity and multiple pregnancies. RESULTS: The incidence of pre-eclampsia was significantly lower in the case group (0.8%) when compared with control group (5.8%) (P = 0.002; odds ratio (OR) = 7.5, 95% confidence interval (CI): 1.7-33.3). Analysis of obstetric outcome in the subgroup of patients with laparoscopic data confirmed the lower risk of pre-eclampsia in the case (1.2%) versus control (7.4%) groups (P = 0.032; OR = 6.6, 95% CI: 1.2-37). PIH occurred in 3.5% and 8.7% of case and control pregnancies, respectively (P = 0.018; OR = 2.6, 95% CI: 1.2-6.0). The odds of developing pre-eclampsia were 5.67 times higher in the control group than in pregnancies following endometriosis-associated infertility. In multiple pregnancies, the odds of developing pre-eclampsia increased 1.93 times per additional child, with or without endometriosis. CONCLUSIONS: We found no evidence that endometriosis predisposes for pre-eclampsia. Instead, the risk of hypertensive disorder in pregnancy is significantly reduced in women with endometriosis-associated infertility. 相似文献
100.
Focks Andreas Belgers Dick Boerwinkel Marie-Claire Buijse Laura Roessink Ivo Van den Brink Paul J. 《Ecotoxicology (London, England)》2018,27(7):992-1007
Ecotoxicology - Exposure patterns in ecotoxicological experiments often do not match the exposure profiles for which a risk assessment needs to be performed. This limitation can be overcome by... 相似文献